Live Breaking News & Updates on Dennis Podlesak|Page 1

Stay updated with breaking news from Dennis podlesak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Reverse Transcriptase Inhibitor Fast Tracked for Progressive Supranuclear Palsy

PSP is a rare, progressive neurodegenerative disorder that affects movement, gait and balance, speech, swallowing, vision, behavior and thinking. ....

Dennis Podlesak , Drug Administration , Fast Track , Chief Executive Officer ,

Transposon Announces Interim Results from a Phase 2 Study of TPN-101 for the Treatment of Progressive Supranuclear Palsy to be Presented at the AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases

24-Week data show TPN-101 is the first treatment for PSP to reduce NfL levels, a key biomarker of neurodegeneration in tauopathies such as PSP and Alzheimer s disease ....

Andrew Satlin , Rick Orr , Dennis Podlesak , International Conference On Alzheimer , Transposon Therapeutics Inc , International Conference , Chief Medical Officer , Chief Executive Officer , Nucleoside Reverse Transcriptase Inhibitor , Progressive Supranuclear Palsy ,

Syndax Appoints Martin H. Huber, M.D., to its Board of Directors

Syndax Appoints Martin H. Huber, M.D., to its Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Baylor College Of Medicine , United States , Rhone Poulenc Rorer , Marty Huber , Dennis Podlesak , Melissa Forst , Martinh Huber , Xilio Therapeutics Inc , Syndax Pharmaceuticals , Board Of Directors Mersana Therapeutics Inc , Tesaro Inc , Oncology Clinical Research At Merck Laboratories , Exchange Commission , Syndax Pharmaceuticals Inc , Chief Medical Officer , Xilio Therapeutics , Senior Vice President , Vice President , Oncology Clinical Research , Merck Research Laboratories , Hoffmann La Roche , Assistant Professor , Mersana Therapeutics , Baylor College , Cautionary Note , Private Securities Litigation Reform Act ,